Details for Patent: 7,592,339

✉ Email this page to a colleague

Summary for Patent: 7,592,339

Scope and claims summary:

Title:	Substituted oxazolidinones and their use in the field of blood coagulation
Abstract:	The invention relates to the field of blood coagulation. Novel oxazolidinone derivatives of the general formula (I) ##STR00001## processes for their preparation and their use as medicinally active compounds for the prophylaxis and/or treatment of disorders are described.
Inventor(s):	Straub; Alexander (Wuppertal, DE), Lampe; Thomas (Wuppertal, DE), Pohlmann; Jens (Wuppertal, DE), Rohrig; Susanne (Essen, DE), Perzborn; Elisabeth (Wuppertal, DE), Schlemmer; Karl-Heinz (Wuppertal, DE), Pernerstorfer; Joseph (Wuppertal, DE)
Assignee:	Bayer Schering Pharma Aktiengesellschaft (Berlin, DE)
Application Number:	11/460,529
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,592,339
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 7,592,339

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 7,592,339

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1261606	⤷ Subscribe	91497	Luxembourg	⤷ Subscribe
European Patent Office	1261606	⤷ Subscribe	PA2008018	Lithuania	⤷ Subscribe
European Patent Office	1261606	⤷ Subscribe	CA 2008 00050	Denmark	⤷ Subscribe
European Patent Office	1261606	⤷ Subscribe	300370	Netherlands	⤷ Subscribe
European Patent Office	1261606	⤷ Subscribe	PA2008018,C1261606	Lithuania	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.